Clearance Summary
Neurolutions Upper Extremity Rehabilitation System received FDA 510(k) clearance under submission number DEN200046, sponsored by Neurolutions, Inc.. The device was reviewed via the Direct premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2021-04-23.
- Submission: DEN200046
- Applicant / Sponsor: Neurolutions, Inc.
- Clearance pathway: Direct
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 890.5420
- Decision date: 2021-04-23
Classification & Regulation
This clearance is catalogued under FDA product code QOL and 21 CFR 890.5420, within the Neurology review panel as a Class II device.